Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Warts 1Triple Negative Breast Neoplasms 1Neoplasms 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Ivermectin × 1 year × Clear all
NCT05318469 2026-05-06

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Cedars-Sinai Medical Center

Phase 1/2 Recruiting
34 enrolled
Breast

Triple Negative Breast Neoplasms

NCT07487805 2026-03-23

ICONIC

University of Florida

Phase 2 Not yet recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT07396714 2026-02-09

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Assiut University

Phase EARLY_PHASE1 Not yet recruiting
88 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡